Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial

Thumbnail
Fulltext:
235079.pdf
Size:
935.8Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Wientjes, M.H.M.
Atiqi, Sadaf
Wolbink, G.J.
Nurmohamed, Michael T.
Boers, Maarten
Rispens, T.
Bemt, B.J.F van den
Broeder, A.A. den
Source
Trials, 22, 1, (2021), article 406
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/235079   https://hdl.handle.net/2066/235079
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.